Attendees:
1004 Venture Partners
3i Partners Fund II LLC
82VS
9vc
Ab Studio Inc.
AbbVie Ventures
Accequa
Acelot, Inc.
Actinogen Medical Ltd.
Age1 Capital Management, LLC
AlbionVC
Alignment Ventures, LLC
Alithia Life Sciences Pty Ltd
Alto Neuroscience Inc.
Alzheimer's Drug Discovery Foundation
Alzinova AB
Amplitude Ventures
Apollo Health Ventures
Aqua Partners LLC
Aquillius Ventures
Argobio Studio
Ariadne Bio
AtaiBeckley
ATEM Capital
Balyasny Asset Management L.P.
Bayland Capital
Bayshore Global Management
Beacon Biosignals, Inc.
BERNINA BioInvest
BioCentury Inc.
BioInnovation Institute
Bioscience Equity Partners
BIOSTART Consulting GmbH
Biovision Ventures
Blackstone Group
Bluezone Capital
Boehringer Ingelheim International GmbH
Bradley Woods & Co. Ltd.
BrainStorm Therapeutics, Inc.
Breslin AG
CABHI Ventures
Canaccord Genuity LLC
CBT Advisors
CITICS CLSA Capital Partners HK Ltd
Claris Ventures SGR S.p.A.
Cognigenics, Inc.
Cognition Therapeutics, Inc.
Coho VC
Collage Venture Partners
Compass Pathways
Coya Therapeutics
DaCapo Brainscience, Inc.
DB Capital, LLC
DeBere Partners Limited
Debiopharm Innovation Fund SA
Decheng Capital LLC
Deerfield Management
Diadem Biotherapeutics, Inc.
Eisai Innovation Inc.
Eli Lilly and Company
Eliraz Ventures
Emory Drug Development Fund
Endurance Bio Inc.
Enveric BioSciences, Inc.
EQT Life Sciences
F. Hoffmann - La Roche AG
F. Hoffmann-La Roche Ltd.
Ferghana Partners, Inc.
Fontaine Capital
Fraser Finance
Frazier Life Sciences
Galimedix Therapeutics, Inc.
Geneer Partners LLC
Generation Fund Life Sciences Fund I
Gilgamesh Pharmaceuticals
Global Asset Capital, LLC
Global BioAccess Fund
Gron Ventures
H. Lundbeck A/S
H.C. Wainwright & Co., LLC
Harness Therapeutics Ltd.
HEST Investments
Hummingbird Ventures
IAG Capital Partners
Innovestor Life Science Ltd.
Intermediate Capital Group PLC
Inveready Asset Management
IPF Partners
Ipsos Healthcare Advisory Service
Jeito Capital
JLS Fund II LP
Johnson & Johnson Innovation – JJDC, Inc.
Johnston Associates, Inc.
Kaleida Capital
KeifeRx LLC
Kerna Ventures
Kidron Capital
L.E.K. Consulting
Ladenburg Thalmann & Co. Inc.
Lafana Life Sciences
Landmark Family Office
LivaNova
LMU Munich
Lumanity
Lumira Ventures
Luson Bioventures, LLC
M Ventures
Mass General Brigham Ventures
Mayo Clinic
MD Anderson Cancer Center
MedinCell S.A
Merck KGaA, Darmstadt, Germany
Merz Therapeutics GmbH
Mesa Verde Venture Partners
Mitsui Global Investment, Inc.
MRL Ventures Fund
MSQ Ventures
National Institutes of Health
Neuro-Innovators, Inc.
Neurvati Neurosciences, Inc.
NI Research Inc.
Nissan Chemical America Corporation
NodThera, Inc.
NovaRadar Bio Venture Corporation
Novatio Ventures
Novo Holdings A/S
Novo Holdings US Inc.
NRx Pharmaceuticals, Inc.
o2h Ventures Ltd.
Oculis SA
OKG Capital LP
Oppenheimer & Co. Inc.
Osmind
Otsuka Pharmaceutical Co., Ltd.
Palo Alto Investors
Palo Santo Fund
Panakès Partners SGR SpA
Pangea Botanica Ltd
Perceptive Advisors, LLC
PgRx Corporation
PJT Partners
Pritzker Neuropsychiatric Disorders Research Consortium
Psilera Inc.
Pullan Consulting
QurCan Therapeutics Inc.
Reunion Neuroscience, Inc.
Roth Capital Partners LLC
Roy Consulting
Samsung Next
Saniona A/S
Satori Neuro Partners LP
Serenatis Bio Ltd.
Seventure Partners
Shanda Grab Ventures Limited
Shionogi & Co., Ltd.
Silicon Valley Venture Growth Partners
Sinaptica Therapeutics, Inc.
Sloan Ventures
Spark Biomedical, Inc.
Star Tree Ventures Ltd.
Strategic Swiss Partners GmbH
Stream Neuroscience Inc.
SV Health Investors
Synthesizer Drug Company, Inc.
Teva Pharmaceutical Industries Ltd.
The Michael J. Fox Foundation for Parkinson's Research
The Venture Collective
TheraVac Biologics
ThinkStern Ventures
Tonix Pharmaceuticals Holding Corp.
Transpacific Venture Capital Partners
UCB Pharma
UNEEG Medical A/S
V-Bio Ventures
V-Bio Ventures BV
Vandria SA
Venture Valuation
VersaPeutics Inc.
Vincere Biosciences Inc.
Vogel BioC
WBB Securities, LLC
Wellington Management
Wellington Partners
WRF Capital
XEIA Venture Partners
Yonjin Venture LLC
Yorkville Advisors Global, LP
Last updated: October 15, 2026